Kiora Pharmaceuticals Stock Performance
| KPRX Stock | USD 2.26 0.08 3.42% |
The company secures a Beta (Market Risk) of 0.99, which conveys possible diversification benefits within a given portfolio. Kiora Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Kiora Pharmaceuticals is expected to follow. Kiora Pharmaceuticals right now secures a risk of 3.27%. Please verify Kiora Pharmaceuticals total risk alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if Kiora Pharmaceuticals will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Kiora Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (3.42) | Five Day Return (4.24) | Year To Date Return 11.88 | Ten Year Return (99.99) | All Time Return (99.99) |
Last Split Factor 1:9 | Dividend Date 2019-08-30 | Last Split Date 2024-06-11 |
1 | Kiora Pharmaceuticals Reports Third Quarter 2025 Results Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases | 11/07/2025 |
2 | Can Kiora Pharmaceuticals Inc. stock sustain free cash flow growth - July 2025 Review Weekly Breakout Watchlists - newser.com | 11/10/2025 |
3 | Will Kiora Pharmaceuticals Inc. stock benefit from infrastructure spending - Earnings Miss Advanced Swing Trade Entry Alerts - newser.com | 11/13/2025 |
4 | Why Kiora Pharmaceuticals Inc. stock signals breakout potential - Weekly Trade Review Real-Time Volume Analysis - newser.com | 11/19/2025 |
5 | Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds | 12/01/2025 |
6 | Why analysts upgrade Kiora Pharmaceuticals Inc. stock - July 2025 Action Free High Accuracy Swing Entry Alerts - | 12/19/2025 |
7 | Acquisition by Melissa Tosca of 5000 shares of Kiora Pharmaceuticals subject to Rule 16b-3 | 01/06/2026 |
8 | Will Kiora Pharmaceuticals Inc. stock announce a stock split - Trade Ideas Risk Controlled Daily Plans - ulpravda.ru | 01/08/2026 |
| Begin Period Cash Flow | 2.5 M | |
| Total Cashflows From Investing Activities | -22.7 M |
Kiora Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 232.00 in Kiora Pharmaceuticals on November 6, 2025 and sell it today you would lose (6.00) from holding Kiora Pharmaceuticals or give up 2.59% of portfolio value over 90 days. Kiora Pharmaceuticals is currently generating 0.0085% in daily expected returns and assumes 3.2717% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than Kiora, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Kiora Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Kiora Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.26 | 90 days | 2.26 | about 24.01 |
Based on a normal probability distribution, the odds of Kiora Pharmaceuticals to move above the current price in 90 days from now is about 24.01 (This Kiora Pharmaceuticals probability density function shows the probability of Kiora Stock to fall within a particular range of prices over 90 days) .
Kiora Pharmaceuticals Price Density |
| Price |
Predictive Modules for Kiora Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kiora Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kiora Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kiora Pharmaceuticals is not an exception. The market had few large corrections towards the Kiora Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kiora Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kiora Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 0.99 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | -0.05 |
Kiora Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kiora Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kiora Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kiora Pharmaceuticals had very high historical volatility over the last 90 days | |
| Latest headline from news.google.com: Will Kiora Pharmaceuticals Inc. stock announce a stock split - Trade Ideas Risk Controlled Daily Plans - ulpravda.ru |
Kiora Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kiora Stock often depends not only on the future outlook of the current and potential Kiora Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kiora Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.1 M | |
| Cash And Short Term Investments | 26.8 M |
Kiora Pharmaceuticals Fundamentals Growth
Kiora Stock prices reflect investors' perceptions of the future prospects and financial health of Kiora Pharmaceuticals, and Kiora Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kiora Stock performance.
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.17 | ||||
| Current Valuation | (10.51 M) | ||||
| Shares Outstanding | 3.68 M | ||||
| Price To Book | 0.40 X | ||||
| Price To Sales | 363.74 X | ||||
| Revenue | 16 M | ||||
| Gross Profit | (3.72 M) | ||||
| EBITDA | 5.7 M | ||||
| Net Income | 3.59 M | ||||
| Cash And Equivalents | 2.43 M | ||||
| Cash Per Share | 2.64 X | ||||
| Total Debt | 57.17 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 1.53 X | ||||
| Book Value Per Share | 6.53 X | ||||
| Cash Flow From Operations | 8.56 M | ||||
| Earnings Per Share | (2.19) X | ||||
| Market Capitalization | 8.61 M | ||||
| Total Asset | 36.48 M | ||||
| Retained Earnings | (143.38 M) | ||||
| Working Capital | 23.7 M | ||||
About Kiora Pharmaceuticals Performance
Evaluating Kiora Pharmaceuticals' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Kiora Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kiora Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.09 | 0.09 | |
| Return On Capital Employed | 0.17 | 0.16 | |
| Return On Assets | 0.09 | 0.09 | |
| Return On Equity | 0.16 | 0.15 |
Things to note about Kiora Pharmaceuticals performance evaluation
Checking the ongoing alerts about Kiora Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kiora Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kiora Pharmaceuticals had very high historical volatility over the last 90 days | |
| Latest headline from news.google.com: Will Kiora Pharmaceuticals Inc. stock announce a stock split - Trade Ideas Risk Controlled Daily Plans - ulpravda.ru |
- Analyzing Kiora Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kiora Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Kiora Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kiora Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kiora Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kiora Pharmaceuticals' stock. These opinions can provide insight into Kiora Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.